XJPX2267
Market cap5.83bUSD
Dec 24, Last price
3,022.00JPY
1D
0.23%
1Q
-6.18%
Jan 2017
-44.24%
Name
Yakult Honsha Co Ltd
Chart & Performance
Profile
Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | 503,079,000 4.14% | 483,071,000 16.37% | 415,116,000 7.62% | |||||||
Cost of revenue | 439,679,000 | 426,383,000 | 370,567,000 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 63,400,000 | 56,688,000 | 44,549,000 | |||||||
NOPBT Margin | 12.60% | 11.73% | 10.73% | |||||||
Operating Taxes | 22,528,000 | 22,636,000 | 20,197,000 | |||||||
Tax Rate | 35.53% | 39.93% | 45.34% | |||||||
NOPAT | 40,872,000 | 34,052,000 | 24,352,000 | |||||||
Net income | 51,006,000 0.72% | 50,641,000 12.74% | 44,917,000 14.39% | |||||||
Dividends | (15,588,000) | (12,712,000) | (9,934,000) | |||||||
Dividend yield | 1.61% | 0.42% | 0.48% | |||||||
Proceeds from repurchase of equity | (29,379,000) | (17,208,000) | (29,753,000) | |||||||
BB yield | 3.04% | 0.57% | 1.42% | |||||||
Debt | ||||||||||
Debt current | 57,985,000 | 54,743,000 | 15,892,000 | |||||||
Long-term debt | 50,187,000 | 33,489,000 | 77,153,000 | |||||||
Deferred revenue | 5,000 | 6,332,000 | 6,299,000 | |||||||
Other long-term liabilities | 10,388,000 | 3,017,000 | 2,869,000 | |||||||
Net debt | (312,784,000) | (313,432,000) | (261,987,000) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 70,702,000 | 86,513,000 | 73,390,000 | |||||||
CAPEX | (46,233,000) | (30,285,000) | (26,725,000) | |||||||
Cash from investing activities | (43,906,000) | (19,024,000) | (11,875,000) | |||||||
Cash from financing activities | (39,541,000) | (44,531,000) | (45,156,000) | |||||||
FCF | (10,570,000) | 24,046,000 | 16,420,000 | |||||||
Balance | ||||||||||
Cash | 255,257,000 | 241,185,000 | 202,941,000 | |||||||
Long term investments | 165,699,000 | 160,479,000 | 152,091,000 | |||||||
Excess cash | 395,802,050 | 377,510,450 | 334,276,200 | |||||||
Stockholders' equity | 675,089,000 | 1,060,854,000 | 962,383,000 | |||||||
Invested Capital | 316,738,950 | 242,932,550 | 238,440,800 | |||||||
ROIC | 14.61% | 14.15% | 10.39% | |||||||
ROCE | 8.51% | 8.79% | 7.49% | |||||||
EV | ||||||||||
Common stock shares outstanding | 310,032 | 312,428 | 320,432 | |||||||
Price | 3,119.00 -67.61% | 9,630.00 47.70% | 6,520.00 16.43% | |||||||
Market cap | 966,989,808 -67.86% | 3,008,681,640 44.01% | 2,089,216,640 16.31% | |||||||
EV | 710,866,808 | 3,217,091,640 | 2,320,265,640 | |||||||
EBITDA | 91,241,000 | 82,021,000 | 68,318,000 | |||||||
EV/EBITDA | 7.79 | 39.22 | 33.96 | |||||||
Interest | 660,000 | 666,000 | 680,000 | |||||||
Interest/NOPBT | 1.04% | 1.17% | 1.53% |